These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33386815)

  • 1. Expression of Transcription Factors in CD4 + T Cells as Potential Biomarkers of Motor Complications in Parkinson's Disease.
    Contaldi E; Magistrelli L; Milner AV; Cosentino M; Marino F; Comi C
    J Parkinsons Dis; 2021; 11(2):507-514. PubMed ID: 33386815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+ T-cell Transcription Factors in Idiopathic REM Sleep Behavior Disorder and Parkinson's Disease.
    De Francesco E; Terzaghi M; Storelli E; Magistrelli L; Comi C; Legnaro M; Mauri M; Marino F; Versino M; Cosentino M
    Mov Disord; 2021 Jan; 36(1):225-229. PubMed ID: 32649001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients.
    Kustrimovic N; Comi C; Magistrelli L; Rasini E; Legnaro M; Bombelli R; Aleksic I; Blandini F; Minafra B; Riboldazzi G; Sturchio A; Mauri M; Bono G; Marino F; Cosentino M
    J Neuroinflammation; 2018 Jul; 15(1):205. PubMed ID: 30001736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional characteristics of CD4+ T cells in multiple sclerosis: relative lack of suppressive populations in blood.
    Edström M; Mellergård J; Mjösberg J; Jenmalm M; Vrethem M; Press R; Dahle C; Ernerudh J
    Mult Scler; 2011 Jan; 17(1):57-66. PubMed ID: 20847001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-35 Is Involved in the Pathogenesis of Guillain-Barré Syndrome Through Its Influence on the Function of CD4+ T Cells.
    Liu H; Zhang W; Tian FF; Kun A; Zhou WB; Xiao B; Li J
    Immunol Invest; 2015; 44(6):566-77. PubMed ID: 26225474
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Acharya S; Lumley AI; Zhang L; Vausort M; Devaux Y; On Behalf Of The Ncer-Pd Consortium
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between circulating CD4+ T lymphocytes and cognitive impairment in patients with Parkinson's disease.
    Magistrelli L; Storelli E; Rasini E; Contaldi E; Comi C; Cosentino M; Marino F
    Brain Behav Immun; 2020 Oct; 89():668-674. PubMed ID: 32688028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dysfunction of CD4+ T lymphocytes in peripheral immune system of Parkinson's disease model mice.
    Huang Y; Liu Z; Wang XQ; Qiu YH; Peng YP
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Nov; 30(6):567-76. PubMed ID: 26016368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered phosphorylated signal transducer and activator of transcription profile of CD4+CD161+ T cells in asthma: modulation by allergic status and oral corticosteroids.
    Gernez Y; Tirouvanziam R; Nguyen KD; Herzenberg LA; Krensky AM; Nadeau KC
    J Allergy Clin Immunol; 2007 Dec; 120(6):1441-8. PubMed ID: 17919711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine Receptor D3 Expression Is Altered in CD4
    Elgueta D; Contreras F; Prado C; Montoya A; Ugalde V; Chovar O; Villagra R; Henríquez C; Abellanas MA; Aymerich MS; Franco R; Pacheco R
    Front Immunol; 2019; 10():981. PubMed ID: 31118938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of polymorphisms and reduced expression levels of the NR4A2 gene with Parkinson's disease in a Mexican population.
    Ruiz-Sánchez E; Yescas P; Rodríguez-Violante M; Martínez-Rodríguez N; Díaz-López JN; Ochoa A; Valdes-Rojas SS; Magos-Rodríguez D; Rojas-Castañeda JC; Cervantes-Arriaga A; Canizales-Quinteros S; Rojas P
    J Neurol Sci; 2017 Aug; 379():58-63. PubMed ID: 28716280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson's disease.
    Saunders JA; Estes KA; Kosloski LM; Allen HE; Dempsey KM; Torres-Russotto DR; Meza JL; Santamaria PM; Bertoni JM; Murman DL; Ali HH; Standaert DG; Mosley RL; Gendelman HE
    J Neuroimmune Pharmacol; 2012 Dec; 7(4):927-38. PubMed ID: 23054369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T Lymphocytes in Parkinson's Disease.
    Contaldi E; Magistrelli L; Comi C
    J Parkinsons Dis; 2022; 12(s1):S65-S74. PubMed ID: 35253782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression characteristics of peripheral blood genes reveal potential biomarkers and candidate therapeutic targets for Parkinson's disease.
    Chen W; Zhou D; Zhu N; Yan X; Jiang G; Zhao L
    Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):118-124. PubMed ID: 32415937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of miR-137 and miR-124 are associated with Parkinson's disease but not with Parkinson's disease with depression.
    Li N; Pan X; Zhang J; Ma A; Yang S; Ma J; Xie A
    Neurol Sci; 2017 May; 38(5):761-767. PubMed ID: 28181066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced Activated T Lymphocytes (CD4+CD25+) and Plasma Levels of Cytokines in Parkinson's Disease.
    Rocha NP; Assis F; Scalzo PL; Vieira ÉLM; Barbosa IG; de Souza MS; Christo PP; Reis HJ; Teixeira AL
    Mol Neurobiol; 2018 Feb; 55(2):1488-1497. PubMed ID: 28176275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson's Disease.
    Chen CH; Lee BC; Lin CH
    J Parkinsons Dis; 2020; 10(1):77-88. PubMed ID: 31868681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in the expression of three markers in T lymphocytes of peripheral blood and immunoregulatory mechanisms of burned mice with sepsis at early stage].
    Zhou Y; Huang P; Zhang P; Ren L; Zeng J; Zhou J; Liang P; Huang X
    Zhonghua Shao Shang Za Zhi; 2016 Feb; 32(2):89-96. PubMed ID: 26902275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral T lymphocyte immunity and l-dopamine in patients with Parkinson's disease.
    Hu ZX; Song WN; Lu XD; Zhou ML; Shao JH
    J Biol Regul Homeost Agents; 2018; 32(3):687-691. PubMed ID: 29921400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical correlation of peripheral CD4+‑cell sub‑sets, their imbalance and Parkinson's disease.
    Chen Y; Qi B; Xu W; Ma B; Li L; Chen Q; Qian W; Liu X; Qu H
    Mol Med Rep; 2015 Oct; 12(4):6105-11. PubMed ID: 26239429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.